|
시장보고서
상품코드
1463115
옥시토신 시장 : 점유율, 규모, 동향, 산업 분석 보고서 : 적응증별, 유통 채널별, 지역별, 부문별 예측(2024-2032년)Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계의 옥시토신 시장 규모는 2032년까지 1억 9,302만 달러에 이를 것으로 예상됩니다. 이 보고서는 현재 시장 역학을 상세하게 인사이트하고 미래 시장 성장에 대한 분석을 제공합니다.
이 시장은 안전하고 효과적인 산과 의료를 선호하는 임산부 건강 관리에 대한 노력 증가로 성장하고 있습니다. 진통 유발과 산후 출혈 관리에 필수적인 옥시토신은 임산부 건강 관리에서 매우 중요한 역할을 합니다. 임산부 사망률을 감소시키고, 양질의 건강 관리에 대한 접근을 강화하고, 산과 진료를 개선하기 위한 노력은 옥시토신 주사 수요 증가에 기여하고 있습니다. 또한 임산부 보건 프로그램에서 필수 의약품의 이용 가능성을 확보하기위한 노력이 시장을 뒷받침하고 있으며, 특히 임산부 보건의 큰 과제에 직면하고 있는 지역에서 임산부의 결과와 산과 의료 전반을 강화하는 데 옥시토신이 중요한 역할을 담당한다는 것이 강조됩니다.
제왕절개 분만의 유병률 증가가 시장을 뒷받침하고 있습니다. 옥시토신은 예정제왕절개나 긴급제왕절개시 진통을 촉진하거나 시작하는데 중요한 역할을 하기 때문입니다. 세계적으로 제왕 절개 분만의 수가 증가하고 있기 때문에 진통 촉진이나 수술 후 자궁 수축을 위한 옥시토신 주사의 필요성이 높아지고 있습니다. 옥시토신은 산후 출혈을 예방하고 제왕 절개시 안전한 분만을 촉진하는 데 필수적입니다.
옥시토신은 사망률의 주요 원인인 PPH를 예방 및 관리하는 데 있어서 매우 중요한 역할을 합니다. 과다 출혈을 통제하는 옥시토신 주사의 구명 효과에 대한 건강 관리 제공업체와 정책 입안자의 의식이 향상되었습니다. PPH 예방의 중요성을 강조하는 모성 건강 프로그램, 캠페인 및 건강 이니셔티브는 옥시토신 주사의 채택을 더욱 자극합니다. 건강 관리 시스템은 PPH 예방에서 옥시토신의 역할에 의해 사망률을 감소시키는 데 도움이 됩니다.
옥시토신 시장 보고서 하이라이트
산후 부문이 가장 큰 점유율을 얻었으며, 이는 임산부의 사망률과 합병증 증가로 인한 것입니다.
병원 부문은 모든 의료 시설을 완비하고 있기 때문에 시장을 독점하고 있습니다.
출산수 증가 및 임산부 건강에 대한 의식 증가로 APAC 지역이 가장 빠르게 성장할 전망입니다.
주요 시장 기업은 Pfizer, Novartis, Ferring, Fresenius Kabi, Hikma Pharmaceuticals, Endo International, Sun Pharmaceutical, Yuhan Corporation 등입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 옥시토신 시장 인사이트
- 옥시토신 시장-업계 스냅샷
- 옥시토신 시장 역학
- 성장 촉진요인 및 기회
- 낙태 및 원치 않는 임신 증가
- 제왕절개 출산 증가
- 억제요인 및 과제
- 시장 접근 및 성장에 영향을 미치는 엄격한 규제
- 성장 촉진요인 및 기회
- PESTLE 분석
- 옥시토신 업계 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 옥시토신 시장 : 적응증별
- 주요 조사 결과
- 서문
- 출산 전
- 산후
제6장 세계의 옥시토신 시장 : 유통 채널별
- 주요 조사 결과
- 서문
- 병원 약국
- 약국
- 온라인 약국
제7장 세계의 옥시토신 시장 : 지역별
- 주요 조사 결과
- 서문
- 옥시토신 시장 평가 : 지역별(2019-2032년)
- 옥시토신 시장-북미
- 북미 : 옥시토신 시장 : 유통 채널별(2019-2032년)
- 북미 : 옥시토신 시장 : 적응증별(2019-2032년)
- 옥시토신 시장-미국
- 옥시토신 시장-캐나다
- 옥시토신 시장-유럽
- 유럽 : 옥시토신 시장 : 유통 채널별(2019-2032년)
- 유럽 : 옥시토신 시장 : 적응증별(2019-2032년)
- 옥시토신 시장-영국
- 옥시토신 시장-프랑스
- 옥시토신 시장-독일
- 옥시토신 시장-이탈리아
- 옥시토신 시장-스페인
- 옥시토신 시장-네덜란드
- 옥시토신 시장-러시아
- 옥시토신 시장-아시아태평양
- 아시아태평양 : 옥시토신 시장 : 유통 채널별(2019-2032년)
- 아시아태평양 : 옥시토신 시장 : 적응증별(2019-2032년)
- 옥시토신 시장-중국
- 옥시토신 시장-인도
- 옥시토신 시장-말레이시아
- 옥시토신 시장-일본
- 옥시토신 시장-인도네시아
- 옥시토신 시장-한국
- 옥시토신 시장-중동 및 아프리카
- 중동 및 아프리카 : 옥시토신 시장 : 유통 채널별(2019-2032년)
- 중동 및 아프리카 : 옥시토신 시장 : 적응증별(2019-2032년)
- 옥시토신 시장-사우디아라비아
- 옥시토신 시장-UAE
- 옥시토신 시장-이스라엘
- 옥시토신 시장-남아프리카
- 옥시토신 시장-라틴아메리카
- 라틴아메리카 : 옥시토신 시장 : 유통 채널별(2019-2032년)
- 라틴아메리카 : 옥시토신 시장 : 적응증별(2019-2032년)
- 옥시토신 시장-멕시코
- 옥시토신 시장-브라질
- 옥시토신 시장-아르헨티나
제8장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 파트너십, 협업, 계약 및 전시회
제9장 기업 프로파일
- Pfizer Inc
- Novartis AG
- Ferring BV
- Fresenius Kabi LLC
- Hikma Pharmaceuticals PLC
- Endo International plc.(Par Sterile Products, LLC)
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Wockhardt Ltd.
- Sun Pharmaceutical Industries Ltd
- Yuhan Corporation
The global oxytocin market size is expected to reach USD 193.02 million by 2032, according to a new study by Polaris Market Research. The report "Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market is experiencing growth driven by increasing initiatives in maternal healthcare, which prioritize safe and effective obstetric care. Oxytocin, essential for labor induction and managing postpartum haemorrhage, plays a pivotal role in maternal healthcare. Efforts to decrease maternal mortality rates, enhance access to quality healthcare, and improve obstetric practices contribute to the rising demand for oxytocin injections. Additionally, endeavors to ensure the availability of essential medicines in maternal health programs are propelling the market, underscoring oxytocin's crucial role in enhancing maternal outcomes and overall obstetric care, particularly in regions facing significant maternal healthcare challenges.
The increasing prevalence of cesarean section deliveries is propelling the market, as oxytocin plays a critical role in enhancing or initiating labor during scheduled and emergency cesarean sections. With a growing number of cesarean deliveries worldwide, the need for oxytocin injections for labor enhancement or post-surgery uterine contraction is escalating. Oxytocin is vital for preventing postpartum haemorrhage and facilitating safe deliveries during cesarean sections.
Oxytocin serves as a crucial intervention in preventing & managing PPH, a primary cause of mortality. Awareness among the healthcare providers & policymakers regarding the life-saving impact of the oxytocin injections in controlling the excessive bleeding. Maternal health programs, campaigns, & health initiatives that emphasize the importance of PPH prevention further stimulate the adoption of oxytocin injections. Healthcare systems helps in reducing the mortality rates, owing to the oxytocin role in preventing the PPH.
Oxytocin Market Report Highlights
Postpartum segment garnered the largest share, owing to rise in maternal mortalities and concerned complications
Hospital segment dominated the market, as they are fully equipped with all medical facilities
APAC will grow at the fastest rate, owing to rise in child births and awareness regarding maternal health
The key market players include Pfizer, Novartis, Ferring, Fresenius Kabi, Hikma Pharmaceuticals, Endo International, Sun Pharmaceutical and Yuhan Corporation
Polaris Market Research has segmented the oxytocin market report based on indication, distribution channel, and region:
Oxytocin, Indication Outlook (Revenue - USD Million, 2019 - 2032)
- Antepartum
- Postpartum
Oxytocin, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
Oxytocin, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of APAC
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of MEA
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Oxytocin Market Insights
- 4.1. Oxytocin Market - Industry Snapshot
- 4.2. Oxytocin Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise in abortion and unwanted pregnancies
- 4.2.1.2. Rise in cesarean deliveries
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Stringent regulations impacting market access and growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Oxytocin Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Oxytocin Market, by Indication
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Oxytocin, by Indication, 2019-2032 (USD Million)
- 5.3. Antepartum
- 5.3.1. Global Oxytocin Market, by Antepartum, by Region, 2019-2032 (USD Million)
- 5.4. Postpartum
- 5.4.1. Global Oxytocin Market, by Postpartum, by Region, 2019-2032 (USD Million)
6. Global Oxytocin Market, by Distribution Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 6.3. Hospital Pharmacies
- 6.3.1. Global Oxytocin Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Million)
- 6.4. Drug Stores
- 6.4.1. Global Oxytocin Market, by Drug Stores, by Region, 2019-2032 (USD Million)
- 6.5. Online Pharmacies
- 6.5.1. Global Oxytocin Market, by Online Pharmacies, by Region, 2019-2032 (USD Million)
7. Global Oxytocin Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
- 7.3. Oxytocin Market - North America
- 7.3.1. North America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.3.2. North America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.3.3. Oxytocin Market - U.S.
- 7.3.3.1. U.S.: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.3.3.2. U.S.: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.3.4. Oxytocin Market - Canada
- 7.3.4.1. Canada: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.3.4.2. Canada: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4. Oxytocin Market - Europe
- 7.4.1. Europe: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.2. Europe: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.3. Oxytocin Market - UK
- 7.4.3.1. UK: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.3.2. UK: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.4. Oxytocin Market - France
- 7.4.4.1. France: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.4.2. France: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.5. Oxytocin Market - Germany
- 7.4.5.1. Germany: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.5.2. Germany: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.6. Oxytocin Market - Italy
- 7.4.6.1. Italy: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.6.2. Italy: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.7. Oxytocin Market - Spain
- 7.4.7.1. Spain: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.7.2. Spain: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.8. Oxytocin Market - Netherlands
- 7.4.8.1. Netherlands: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.8.2. Netherlands: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.4.9. Oxytocin Market - Russia
- 7.4.9.1. Russia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.4.9.2. Russia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5. Oxytocin Market - Asia Pacific
- 7.5.1. Asia Pacific: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.5.2. Asia Pacific: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.3. Oxytocin Market - China
- 7.5.3.1. China: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.5.3.2. China: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.4. Oxytocin Market - India
- 7.5.4.1. India: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.5.4.2. India: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.5. Oxytocin Market - Malaysia
- 7.5.5.1. Malaysia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.5.5.2. Malaysia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.6. Oxytocin Market - Japan
- 7.5.6.1. Japan: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.5.6.2. Japan: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.7. Oxytocin Market - Indonesia
- 7.5.7.1. Indonesia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.5.7.2. Indonesia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.5.8. Oxytocin Market - South Korea
- 7.5.8.1. South Korea: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.5.8.2. South Korea: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6. Oxytocin Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.6.2. Middle East & Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6.3. Oxytocin Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.6.3.2. Saudi Arabia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6.4. Oxytocin Market - UAE
- 7.6.4.1. UAE: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.6.4.2. UAE: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6.5. Oxytocin Market - Israel
- 7.6.5.1. Israel: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.6.5.2. Israel: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.6.6. Oxytocin Market - South Africa
- 7.6.6.1. South Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.6.6.2. South Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.7. Oxytocin Market - Latin America
- 7.7.1. Latin America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.7.2. Latin America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.7.3. Oxytocin Market - Mexico
- 7.7.3.1. Mexico: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.7.3.2. Mexico: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.7.4. Oxytocin Market - Brazil
- 7.7.4.1. Brazil: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.7.4.2. Brazil: Oxytocin Market, by Indication, 2019-2032 (USD Million)
- 7.7.5. Oxytocin Market - Argentina
- 7.7.5.1. Argentina: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.7.5.2. Argentina: Oxytocin Market, by Indication, 2019-2032 (USD Million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Pfizer Inc
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Novartis AG
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Ferring B.V
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Fresenius Kabi LLC
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Hikma Pharmaceuticals PLC
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Endo International plc. (Par Sterile Products, LLC)
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Teva Pharmaceutical Industries Ltd.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Mylan N.V.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Wockhardt Ltd.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Sun Pharmaceutical Industries Ltd
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Yuhan Corporation
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
